There is no single best weight loss drug, as effectiveness and suitability depend on individual health status, goals, and tolerability
A total of 579 patients were randomized (1:1) to either the MTD (10 mg or 15 mg) of tirzepatide or a matching placebo, given by once-weekly subcutaneous injection for 72 weeks
These medications typically take 30 to 60 minutes to achieve an erection3
Individuals with known sensitivity to glutathione
Preliminary data suggest tirzepatide was non-inferior to dulaglutide for the primary composite endpoint of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke
Impulse Control and Addiction: Some preclinical studies have even suggested that the melanocortin system, particularly via the MC4R, may play a role in addictive behaviors, opening yet another avenue for investigation with MT-2